David Grossman
Stock Analyst at Stifel
(3.66)
# 841
Out of 4,734 analysts
153
Total ratings
56.6%
Success rate
4.23%
Average return
Main Sectors:
Stocks Rated by David Grossman
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACCD Accolade | Downgrades: Hold | $8 → $7.03 | $6.88 | +2.18% | 6 | Jan 9, 2025 | |
VEEV Veeva Systems | Maintains: Buy | $240 → $272 | $223.04 | +21.95% | 7 | Dec 6, 2024 | |
OPRX OptimizeRx | Maintains: Buy | $13 → $8 | $5.41 | +47.87% | 6 | Nov 14, 2024 | |
IBM International Business Machines | Maintains: Buy | $205 → $246 | $224.26 | +9.69% | 20 | Oct 16, 2024 | |
PAYX Paychex | Maintains: Hold | $130 → $141 | $145.66 | -3.20% | 9 | Oct 2, 2024 | |
TDOC Teladoc Health | Maintains: Hold | $16 → $9 | $9.50 | -5.26% | 10 | Aug 1, 2024 | |
ADP Automatic Data Processing | Maintains: Hold | $271 → $287 | $298.15 | -3.74% | 10 | Aug 1, 2024 | |
DH Definitive Healthcare | Maintains: Buy | $9.5 → $7.5 | $4.41 | +70.07% | 3 | Jul 31, 2024 | |
ACN Accenture | Maintains: Buy | $395 → $340 | $356.42 | -4.61% | 25 | Jun 12, 2024 | |
DXC DXC Technology Company | Maintains: Hold | $21 → $19 | $20.87 | -8.96% | 10 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6.5 | $4.31 | +50.81% | 8 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $0.71 | +463.38% | 3 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $121 | $93.73 | +29.09% | 11 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $288 → $301 | $237.36 | +26.81% | 11 | Feb 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $12 | $5.68 | +111.27% | 4 | Nov 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Positive | $22 → $29 | $21.15 | +37.12% | 9 | Jan 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $580 | $10.98 | +5,182.33% | 1 | Dec 18, 2020 |
Accolade
Jan 9, 2025
Downgrades: Hold
Price Target: $8 → $7.03
Current: $6.88
Upside: +2.18%
Veeva Systems
Dec 6, 2024
Maintains: Buy
Price Target: $240 → $272
Current: $223.04
Upside: +21.95%
OptimizeRx
Nov 14, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $5.41
Upside: +47.87%
International Business Machines
Oct 16, 2024
Maintains: Buy
Price Target: $205 → $246
Current: $224.26
Upside: +9.69%
Paychex
Oct 2, 2024
Maintains: Hold
Price Target: $130 → $141
Current: $145.66
Upside: -3.20%
Teladoc Health
Aug 1, 2024
Maintains: Hold
Price Target: $16 → $9
Current: $9.50
Upside: -5.26%
Automatic Data Processing
Aug 1, 2024
Maintains: Hold
Price Target: $271 → $287
Current: $298.15
Upside: -3.74%
Definitive Healthcare
Jul 31, 2024
Maintains: Buy
Price Target: $9.5 → $7.5
Current: $4.41
Upside: +70.07%
Accenture
Jun 12, 2024
Maintains: Buy
Price Target: $395 → $340
Current: $356.42
Upside: -4.61%
DXC Technology Company
May 17, 2024
Maintains: Hold
Price Target: $21 → $19
Current: $20.87
Upside: -8.96%
Apr 30, 2024
Maintains: Buy
Price Target: $8 → $6.5
Current: $4.31
Upside: +50.81%
Apr 1, 2024
Maintains: Buy
Price Target: $4
Current: $0.71
Upside: +463.38%
Feb 16, 2024
Maintains: Buy
Price Target: $117 → $121
Current: $93.73
Upside: +29.09%
Feb 12, 2024
Maintains: Buy
Price Target: $288 → $301
Current: $237.36
Upside: +26.81%
Nov 1, 2023
Maintains: Hold
Price Target: $15 → $12
Current: $5.68
Upside: +111.27%
Jan 10, 2022
Upgrades: Positive
Price Target: $22 → $29
Current: $21.15
Upside: +37.12%
Dec 18, 2020
Initiates: Hold
Price Target: $580
Current: $10.98
Upside: +5,182.33%